We have appeared before this committee before on the question of the re-evaluations with PMRA, and this committee wrote a very helpful letter to the then minister of health, highlighting some of the predictability concerns we had with the process of re-evaluation of PMRA. That language was very helpful. It hasn't changed the situation as of yet, but we're hopeful we're on the right path for that. There are some very specific process issues, for lack of a better term, with the regulators that we could use some support on.
On the plant breeding innovations, I talked earlier about a tiered approach to assessment. We've made very concrete, very specific, and, we feel, well-thought-out proposals. We need a receptive ear. That would be a tremendous help to pave the way for the regulators to consider some of these ideas.